A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation-Reference-Cited by-同舟云学术

A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation

Published:2012-08-26 Issue:10 Volume:44 Page:1122-1125
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Jenkins Robert B,Xiao Yuanyuan,Sicotte Hugues,Decker Paul A,Kollmeyer Thomas M,Hansen Helen M,Kosel Matthew L,Zheng Shichun,Walsh Kyle M,Rice Terri,Bracci Paige,McCoy Lucie S,Smirnov Ivan,Patoka Joseph S,Hsuang George,Wiemels Joe L,Tihan Tarik,Pico Alexander R,Prados Michael D,Chang Susan M,Berger Mitchel S,Caron Alissa A,Fink Stephanie R,Halder Chandralekha,Rynearson Amanda L,Fridley Brooke L,Buckner Jan C,O'Neill Brian P,Giannini Caterina,Lachance Daniel H,Wiencke John K,Eckel-Passow Jeanette E,Wrensch Margaret R

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.2388.pdf

Reference35 articles.

1. Shete, S. et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 41, 899–904 (2009).

2. Jenkins, R.B. et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet. 204, 13–18 (2011).

3. Sanson, M. et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum. Mol. Genet. 20, 2897–2904 (2011).

4. Rice, T. et al. Associations of glioma risk loci by IDH1 mutation status. Neuro-oncol. 13 (suppl. 3), iii27 (2011).

5. Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009).

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis;Frontiers in Oncology;2023-09-07

2. Differential expression of the circadian clock network correlates with tumour progression in gliomas;BMC Medical Genomics;2023-07-03

3. Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers;Cells;2023-06-29

4. Gliomes avec mutation d’un gène IDH;médecine/sciences;2023-06

5. Mutational landscape of primary spinal cord astrocytoma;The Journal of Pathology;2023-04-28